SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001174947-23-001251
Filing Date
2023-10-30
Accepted
2023-10-30 13:20:31
Documents
2
Group Members
MARK E. STROMESTROME ALPHA FUND, L.P.STROME GROUP, INC.STROME INVESTMENT MANAGEMENT, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13D ea187380-13da6strome_zivobio.htm SC 13D/A 127606
2 DEBT EXTENSION AND CONVERSION AGREEMENT, DATED MARCH 3, 2021, BY AND AMONG STROM ea187380ex99-8_zivobio.htm EX-99.8 20413
  Complete submission text file 0001174947-23-001251.txt   149921
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Subject) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79359 | Film No.: 231359285
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 WILSHIRE BLVD., SUITE 1750 SANTA MONICA CA 90401
Business Address 100 WILSHIRE BLVD., SUITE 1750 SANTA MONICA CA 90401 3109176600
STROME MEZZANINE FUND, LP (Filed by) CIK: 0001713153 (see all company filings)

IRS No.: 272464666 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A